We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Contrast Medium Enhanced Post-mortem CT in Virtual Autopsy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01541995
First Posted: March 1, 2012
Last Update Posted: September 30, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Universitätsklinikum Hamburg-Eppendorf
  Purpose
The study aims to compare the value of contrast medium enhanced post mortem CT to classic autopsy.

Condition
Thromboembolism Vascular Conditions

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Further study details as provided by Universitätsklinikum Hamburg-Eppendorf:

Biospecimen Retention:   Samples Without DNA
Histology

Enrollment: 50
Study Start Date: April 2012
Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
virtual and classic autopsy
Patients where contrast medium enhanced post mortem CT and classic autopsy will be performed.
virtual autopsy only
Patients where only contrast medium enhanced post mortem CT will be performed.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
patients dying in the ICU during the study period
Criteria

Inclusion Criteria:

  • Patients dying in the ICU
  • age >18y

Exclusion Criteria:

  • relatives refusing to participation in the study
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01541995


Locations
Germany
University Medical Center Hamburg-Eppendorf
Hamburg, Germany, 20246
Sponsors and Collaborators
Universitätsklinikum Hamburg-Eppendorf
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Universitätsklinikum Hamburg-Eppendorf
ClinicalTrials.gov Identifier: NCT01541995     History of Changes
Other Study ID Numbers: VA-3 Contrast Medium
First Submitted: February 24, 2012
First Posted: March 1, 2012
Last Update Posted: September 30, 2013
Last Verified: September 2013

Keywords provided by Universitätsklinikum Hamburg-Eppendorf:
contrast medium enhanced post mortem CT
virtual autopsy
To evaluate the value of contrast medium enhanced post-mortem CT in virtual autopsy focussing on thromboembolic and vascular conditions

Additional relevant MeSH terms:
Thromboembolism
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases